Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

Keyphrases

• Chemokines 100%
• Validation Studies 100%
• Interferon-α (IFN-α) 100%
• SLE Disease Activity Index (SLEDAI) 100%
• Systemic Lupus Erythematosus 60%
• Disease Activity 60%
• Systemic Lupus Erythematosus Patient 60%
• Serum Chemokine 60%
• Serum Levels 40%
• Monocyte Chemoattractant protein-1 (MCP-1) 20%
• Disease Biomarker 20%
• Autoimmune Disease 20%
• Severe Disease 20%
• Clinical Decision-making 20%
• Disease Flare 20%
• Stimulator of Interferon Genes (STING) 20%
• Irreversible Damage 20%
• CCL19 20%
• Multiple Baseline 20%
• Clinic Visits 20%
• Macrophage Inflammatory Protein 1α 20%
• Active Disease 20%
• Multiple Organs 20%
• Chemokine (C-C motif) Ligand 2 (CCL2) 20%
• CXCL10 20%
• Lupus Activity 20%
• Lupus Flare 20%
• Gene Signature 20%
• Activity Biomarkers 20%

Immunology and Microbiology

• Interferon Type I 100%
• Systemic Lupus Erythematosus 100%
• Chemokine 100%
• Lupus Erythematosus 20%
• Blood Level 20%
• Macrophage Inflammatory Protein 10%
• Monocyte Chemotactic Protein 1 10%
• Autoimmune Disease 10%
• Laboratory Test 10%
• Gene Expression Profiling 10%
• Organ Systems 10%
• CCL2 10%
• Clinical Decision Making 10%
• CXCL10 10%
• CCL19 10%